Philippine DOH plans to use China's Sinopharm vaccine

MANILA, Philippines, May 10 (The Inquirer/ANN) — The Department of Health (DOH) is set to file on Monday an application for emergency use authorization (EUA) for the COVID-19 vaccine developed by China’s state-owned drugmaker Sinopharm.

This is after the World Health Organization (WHO) approved the vaccine for emergency use, making it the first shot developed by a non-Western country to secure WHO approval.

“Ngayong umaga, ang DOH mag-aapply ng EUA sa Food and Drug Administration for Sinopharm dahil mayroon nang EUL (emergency use listing) na nilabas ng WHO kahapon o nung makalawa, ” Duque said in an interview on ABS CBN’s TeleRadyo.

(This morning, the DOH will apply for an EUA before the FDA for Sinopharm because it already has an EUL from the WHO.)

An EUA would allow a vaccine under development to be used in the country.

The FDA earlier said there is no pending EUA application for the Sinopharm vaccine but three companies have so far expressed interest to apply.

President Rodrigo Duterte earlier got inoculated with the donated Sinopharm vaccine sans an EUA.

Article type: metered
User Type: anonymous web
User Status:
Campaign ID: 46
Cxense type: free
User access status: 3

Next In Aseanplus News

Singapore's 2021 GDP growth outlook looks much better now, say professional forecasters
China sees nearly 90 million domestic tourist trips during festival
Junta trial of Myanmar's ousted leader Suu Kyi gets underway
Two rare Javan rhino calves spotted in Indonesia
Ex-head of Myanmar's Covid-19 vaccination programme arrested
38, 000 Filipinos find Jordan second home, says Philippines envoy
Virus outbreaks at Thai factories threaten export sector, recovery
Emerging markets: Indonesian rupiah falls on virus concerns; Asia forex eyes Fed meeting
Hana Financial Group wins preliminary nod to set-up asset management company in Singapore
Bangkok hospitals postpone Covid-19 shots, citing vaccine shortages

Stories You'll Enjoy